Perhaps you are familiar with the following:
- PEGINTRON® was the first alpha interferon approved by the Food and Drug Administration (FDA) for once-weekly dosing.
- The PEGINTRON® REDIPEN® is the first and only pen delivery system approved for administering pegylated interferon therapy for chronic hepatitis C — an easy-to-use alternative to traditional vial and syringe.
Did you also know that patients surveyed said that the PEGINTRON® REDIPEN® gives them the features they want in an injection system?1 The reasons for this included:
- Precise delivery of the exact prescribed dose
- The shortest, thinnest needle (30 gauge) available for pegylated interferon treatment
- The latest injection technology
The PEGINTRON® REDIPEN® is not a syringe. This system measures the dose you should take, and its innovative design allows you to inject yourself comfortably just by following your doctor's instructions. Learn how to use the PEGINTRON® REDIPEN® or read more about its Features & Benefits.
Effective chronic hepatitis C treatment means taking a disciplined approach to improving your condition. Sign up for the The Be In Charge® Program - a toll-free service that provides nurse support in 150 languages. Visit www.beincharge.com and sign-up to receive regular e-mail reminders that will notify you when it's time to administer medication or meet with your health care provider.
1 Data on file, Schering Corporation.
